Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfluramine in Sunflower Syndrome
NCT03790137Phase 3Completed
- Start
- May 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fenfluramine in Sunflower syndrome. Primary endpoints: % Change in Frequency of Handwaving Episodes at Month 3 and Change in Frequency of Generalized Tonic-clonic Seizures at Month 3. Started May 2019; status: completed.
02
Drugs
fenfluramine
03
Conditions
Sunflower syndrome
Beyond the preview
Go deeper on NCT03790137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790137.